• Amr MorsiEmail author


The endocrinology chapter reviews many of the disorders pediatricians encounter in their practice, including disorders of growth, puberty, calcium metabolism, adrenal gland, thyroid gland, pituitary gland, diabetes, and disorders of sexual differentiation. Background information is provided to aid in understanding the principles behind diagnosis and management. Additional Pearls and Pitfalls can be found at the end of the chapter.


Growth Pituitary gland Neonatal hypoglycemia Craniopharyngioma Diabetes insipidus Syndrome of inappropriate antidiuretic hormone secretion (SIADH) Cerebral salt wasting Hyperpituitarism Gigantism Acromegaly Prolactinoma Congenital hypothyroidism Hashimoto thyroiditis Graves disease Thyroid cancer Hypoparathyroidism Hyperparathyroidism Rickets Congenital adrenal hyperplasia Cushing syndrome Addison disease Klinefelter syndrome Turner syndrome Polycystic ovary disease Denys-Drash syndrome Type 1 diabetes mellitus Type 2 diabetes mellitus Diabetes ketoacidosis Maturity onset diabetes of youth (MODY) Obesity 



The author gratefully acknowledges the contributions of Kuk-Wha Lee, MD, PhD, Division of Endocrinology, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA, to the 1st edition of this chapter, many of which have been incorporated into this edition as well.

Suggested Reading

  1. American Diabetes Association. 13. Children and adolescents: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S148–64. Review.Google Scholar
  2. Anderson BJ, Edelstein S, Abramson NW, Katz LE, Yasuda PM, Lavietes SJ, et al. Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study. Diabetes Care. 2011;34(10):2205–7.CrossRefGoogle Scholar
  3. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123(4):e752–62. Review.CrossRefGoogle Scholar
  4. Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86(6):361–97.CrossRefGoogle Scholar
  5. Lee PA, Houk CP, Ahmed SF, Hughes IA, International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488–500.CrossRefGoogle Scholar
  6. Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043–88.CrossRefGoogle Scholar
  7. Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, Pediatric Endocrine Society, et al. Recommendations from the Pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167(2):238–45.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Endocrinology, Department of PediatricsUPMC Children’s Hospital of PittsburghPittsburghUSA

Personalised recommendations